Journal of Cutaneous Immunology and Allergy | New and Recent Articles https://www.frontierspartnerships.org/journals/journal-of-cutaneous-immunology-and-allergy RSS Feed for Journal of Cutaneous Immunology and Allergy | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-04-09T00:41:18.479+00:00 60 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16386 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16386 <![CDATA[Immune perturbation in arsenic-induced adverse health effects and cancers]]> 2026-03-30T00:00:00Z Review Chien-Hui HongSebastian YuShu-Li WangHsin-Su YuChih-Hung Lee https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16180 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16180 <![CDATA[Case Report: A case with Xeroderma pigmentosum type F manifested a mild phenotype due to a deep intronic variant of the ERCC4 gene]]> 2026-03-20T00:00:00Z Case Report Mei TochigiYuko TakamiyaMegumi MoritaKazushi AnzawaAkira ShimizuSumihito TogiHiroki UraYo Niida A. This variant causes aberrant mRNA splicing, which confirmed the diagnosis of XP. Seven cases with the same intronic variant have been reported in Japan. In our case, we independently analyzed the qualitative and quantitative aspects of abnormal mRNA splicing, which had not been reported previously, and found approximately 7.7% of the mRNA retained normal splicing. Furthermore, immunostaining of patient’s skin with anti-ERCC4/XP antibody confirmed that the ERCC4 protein was partially expressed rather than being completely absent. This partial expression was predicted to be associated with the relatively mild phenotype observed in our patient.]]> https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.15800 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.15800 <![CDATA[The epidemiological and clinical association between primary focal hyperhidrosis and various skin disease in Japanese patients: outpatient questionnaire analysis]]> 2026-02-23T00:00:00Z Original Research Keiji KosakaAkihiko UchiyamaMai IshikawaSei-Ichiro Motegi https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16328 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16328 <![CDATA[Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model]]> 2026-02-20T00:00:00Z Correction Akihiko UchiyamaBayarmaa TaivanbatKeiji KosakaMai IshikawaAkihito UeharaMasatoshi ShimaokaKeiichiro RyuzakiSei-Ichiro Motegi https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16078 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.16078 <![CDATA[Exacerbation of hand rash after dupilumab initiation in a child with atopic dermatitis who was able to continue treatment]]> 2026-02-05T00:00:00Z Letter to the Editor Kanoko KonoTakashi SakaiYutaka Hatano https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.15453 https://www.frontierspartnerships.org/articles/10.3389/jcia.2026.15453 <![CDATA[Coexistence of lichenoid and psoriasiform eruptions following PD-1 blockade immunotherapy]]> 2026-01-22T00:00:00Z Letter to the Editor Tatsuya OgawaShin MatsumotoKeiji TabuchiToshifumi Nomura https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15953 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15953 <![CDATA[Cicatricial alopecia of the scalp as a manifestation of IgG4-related disease mimicking acne keloidalis nuchae]]> 2026-01-07T00:00:00Z Letter to the Editor Ayame SuwayamaTomoko KaminagaShujiro HayashiShown TokoroKen Igawa https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15491 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15491 <![CDATA[Modulation of keratinocyte proliferation, migration, and differentiation by calcium and magnesium]]> 2025-12-09T00:00:00Z Original Research Kazushi HirakataMiyabi HiyamaHideyuki ItabashiAkihiko UchiyamaSei-Ichiro Motegi https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15763 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15763 <![CDATA[Case Report: Dermatomyositis with symmetrical axillary and inguinal panniculitis associated with anti-NXP-2]]> 2025-12-01T00:00:00Z Case Report Eri UchiyamaMei TochigiYuko TakamiyaAkira ShimizuTakashi MatsushitaKazunori Yamada https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15760 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15760 <![CDATA[Diagnostics of cutaneous adverse drug reactions: evaluation of patch tests, lymphocyte transformation tests, and drug provocation tests]]> 2025-11-27T00:00:00Z Brief Research Report Tomomu IshikawaRisa Tamagawa-MineokaKoji MasudaNorito KatohTakeshi Fukumoto https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15510 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15510 <![CDATA[Temporal dynamics of cytokine production balance between innate and adaptive lymphocytes in atopic dermatitis model mice]]> 2025-11-20T00:00:00Z Letter to the Editor Mai NishimuraYoshiaki MatsushimaYasutomo ImaiKeiichi Yamanaka https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15613 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15613 <![CDATA[Changes in biologic treatment patterns for psoriasis before and after the COVID-19 pandemic in Japan; a single center retrospective study]]> 2025-11-17T00:00:00Z Letter to the Editor Natsumi IkumiHideki Fujita https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15280 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15280 <![CDATA[Case Report: Blister formation with transient drug hypersensitivity following CAR-T-cell therapy]]> 2025-10-08T00:00:00Z Case Report Natsu WatanabeNobuo KanazawaSatoshi Yoshihara https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15151 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15151 <![CDATA[The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model]]> 2025-09-22T00:00:00Z Original Research Akihiko UchiyamaBayarmaa TaivanbatKeiji KosakaMai IshikawaAkihito UeharaMasatoshi ShimaokaKeiichiro RyuzakiSei-Ichiro Motegi https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15322 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15322 <![CDATA[Case Report: First reports of Schnitzler syndrome in Iran: clinical presentation and therapeutic challenges]]> 2025-09-11T00:00:00Z Case Report Mohammad AminianfarSaeed Soleiman-MeigooniShadi MohammadiMahdieh Aminianfar https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15043 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15043 <![CDATA[Two cases of severe childhood-onset psoriasis successfully treated with risankizumab in patients with Down syndrome and morbid obesity]]> 2025-08-14T00:00:00Z Letter to the Editor Yoshiaki HaraTomomitsu MiyagakiTatsuro OkanoTakafumi KadonoHidenori Watabe https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15227 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15227 <![CDATA[Association between the neutrophil percentage-to-albumin ratio and generalized pustular psoriasis]]> 2025-08-11T00:00:00Z Letter to the Editor Arisa YoshimuraShinichi SatoSayaka Shibata https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14936 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14936 <![CDATA[Severe lichenified skin rash associated with apalutamide administration]]> 2025-07-22T00:00:00Z Letter to the Editor Chisato WatanabeShujiro HayashiShown TokoroKen Igawa https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15049 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.15049 <![CDATA[Successful conservative management of massive oxaliplatin extravasation from a central venous port with early systemic corticosteroid therapy]]> 2025-07-14T00:00:00Z Letter to the Editor Shunsuke TakahagiMayu KanamotoHikari Sakamoto https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14843 https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14843 <![CDATA[Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitor]]> 2025-07-10T00:00:00Z Letter to the Editor Yukiko Nakahara-OmoriYukari KobayashiSumiko IshizakiKyoko ChujoChikako SutoMasaru TanakaNoriko Umegaki-Arao